Shy Zyman, CEO

Shy has over two decades of experience in business development, sales and marketing in the high-tech sector. He is the former CEO of two start-up companies and co-founded a leading business development firm. As a senior VP for International Sales at Viora, he enjoyed outstanding success. His experience in the Medical Device market and emerging Medical Aesthetics is driving EnerJet’s emergence as a leading compound delivery platform with huge potential.

Shiri Moskovich, CPA, Chief Financial Officer

Shiri is a Certified Public Accountant with an MBA degree specialization in finance and over a decade of experience working with both privately-held and publically-traded companies. Before joining the EnerJet team, she worked at Price Waterhouse, gaining extensive experience in accounting, maintaining and auditing financial records, managing budgets, risk assessment and business strategy.

Ariel Nezry, Vice President of Marketing & Sales

Ariel joined the EnerJet team in 2014 after ten years of success as VP of Marketing & Sales for SharpLight Technologies, an aesthetic device company. Ariel holds a degree in Business Management degree from the Open University in Israel.

Hagai Sroussi, Vice President R&D

With a degree in mechanical Engineering from the prestigious Technion-Israel institute of Technology, Hagai brings valuable expertise and experience to the EnerJet team in multi-disciplinary R&D and product development, specializing in medical devices.

Dr. Yuri Vinshtok, Director of Clinical Research

Dr. Yuri Vinshtok currently serves as Clinical Research Director at PerfAction Technologies. For the past ten years, Dr. Vinshtok held clinical management positions in various medical device and pharma companies including Deep Breathe, Medispec, Urogen (former TheraCoat). Dr. Yuri Vinshtok graduated from the medical school (Russia) in 1984 and brings over 20 years of experience in practical medicine. In addition, he holds Master of Public Administration degree from the City University of New York (USA).

Alon Maor, Chairman

Alon Maor brings an extensive background in healthcare and medical aesthetics to PerfAction, with over 22 years’ experience in the medical device business.
in 2004, Alon founded Aesthera Corporation – a Kleiner Perkins-backed innovator of light-based technologies for skin treatments. He was CEO and Chairman from Aesthera’s inception through its acquisition by Solta Medical in 2010. Prior to this, he was Executive Vice President and General Manager of the Aesthetic Business Unit at Lumenis. Previously, he established ESC’s Asia operations, acting as CEO and growing the business to $38 million. Before this, Alon spent 10 years at Direx Medical Systems, during which he established Direx Japan as a leading player in diagnostic and therapeutic systems.

Shai Levi

Mr. Shai Levy has been the CEO of ProSeed Venture Capital Fund Ltd (traded on the Tel Aviv Stock Exchange as TLV:PRSD) since 2012. Mr. Levy has a key role in managing ProSeed fund’s investments, deal flow, financing and M&A as well as serving on a variety of companies Board of Directors in a wide range of industries.

Mr. Levy gained broad-based management experience with investments in the U.S, Europe and Israel in various sectors mostly focusing on High-Tech, Real Estate and Family Office.

Prior to Joining ProSeed, Mr. Levy served as the Chief Financial & Investment Officer for the Tahari Family in New York for over 5 years, as Director of Financial Reporting & Compliance at the Deutsch Inc, New York (a part of Interpublic Group NYSE:IPG), auditor at PwC, New York and at Ernst and Young Israel.

Mr. Levy holds a Bachelor’s degree in Accounting and Finance from Tel-Aviv University and is a Certified Public Accountant (CPA) in Israel.

Dr. Adina Makover

Dr. Adina Makover currently holds the position of Director of Life Sciences Investments at Proseed VC and serves as a director of the board at several public and private companies. Previously, Dr. Makover has been the managing director of Tzina Bio Perspective, a private investment company focusing on biotechnology and medical device ventures. The investment career follows senior management positions in biotech and device companies, focusing on drugs, diagnostics and tissue engineering, holding positions of CEO, R&D, process development and production manager.

Dr. Makover holds a joint PhD degree in life sciences from Columbia University (USA) and Weizmann Institute of Science (Israel) and performed post-doctoral research at the Weizmann Institute of Science. Dr. Makover also holds an MBA degree from Bar-Ilan University.

Yacha Sutton

Yacha brings to PerfAction over 30 years’ experience in the field of Medical Equipment. In 1981 assisted in the IPO of Laser Industries on Nasdaq and joined the Board of Directors and the Executive Committee of the Company. In 1990 joined Laser Industries as Executive Vice President & CFO and in 1995 was appointed President and COO. Company sold in February 1998 for $270M to ESC Medical Systems. In 1999 was asked to assume the CEO position of ESC Medical Systems. Conducted a major restructuring program and turned the company to profitability in 2000. Led a major acquisition in 2001 of the Coherent Medical Group. In last ten years President of Rugby Investments Ltd, a self owned company that invests in startup companies primarily in Medical Equipment.